Results 111 to 120 of about 699,568 (298)
Clinical factors influencing the efficacy of pooled platelet transfusions [PDF]
, 1988 JF Bishop, Kathy McGrath, M. Wolf, JP Matthews, T De Luise, Rhonda Holdsworth, K. Yuen, Margaret F. Veale, MG Whiteside, I. A. Cooper +9 moreopenalex +1 more sourceAntigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice
, 2021 Connie M. Arthur, Jerry William Lynn Allen, Hans Verkerke, Justin Yoo, Ryan Philip Jajosky, Kathryn R. Girard‐Pierce, Satheesh Chonat, Patricia E. Zerra, Cheryl L. Maier, Jen Rha, Ross M. Fasano, Cassandra D. Josephson, John D. Roback, Sean R. Stowell +13 moreopenalex +1 more sourceTransfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
Journal of the American Medical Association (JAMA), 2015 J. Holcomb, B. Tilley, S. Baraniuk, E. Fox, C. Wade, J. Podbielski, D. D. del Junco, K. Brasel, E. Bulger, R. Callcut, M. Cohen, B. Cotton, T. Fabian, K. Inaba, J. Kerby, P. Muškát, T. O'keeffe, S. Rizoli, B. Robinson, T. Scalea, M. Schreiber, D. Stein, J. Weinberg, J. Callum, J. Hess, N. Matijevic, Christopher N. Miller, J. Pittet, D. Hoyt, G. Pearson, B. Leroux, G. van Belle +31 moresemanticscholar +1 more sourceProspective, Multicenter Evaluation of Transcarotid Artery Revascularization in Standard‐Risk Patients: 30‐Day Outcomes of the ROADSTER 3 Study
Annals of Neurology, EarlyView.Objective
To evaluate the real‐world safety and efficacy for standard surgical risk patients with extracranial internal carotid artery disease undergoing transcarotid artery revascularization. Methods
ROADSTER 3 is a prospective, multicenter, single‐arm post‐approval study.Jeffrey Jim, Meghan Dermody, Brian Peterson, Scott S. Berman, Nicolas J. Mouawad, Joseph Ricotta, Naveed Saqib, Peter Faries, Angela Martin, Joshua D. Adams, Uttam Tripathy, Daniel Calderon, David O'Connor, Rasesh Shah, Sumaira Macdonald, Marc L. Schermerhorn +15 morewiley +1 more sourceEfficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial [PDF]
, 2013 Keyvan Karkouti, Christian von Heymann, Christian M. Jespersen, Wolfgang Korte, Jerrold H. Levy, Marco Ranucci, Frank W. Sellke, Howard K. Song +7 moreopenalex +1 more sourceAmerican College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel
Arthritis &Rheumatology, EarlyView.Objective
Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.Arsene Mekinian, Sophie Georgin‐Lavialle, Marcela A. Ferrada, Sinisa Savic, Matthew J. Koster, Olivier Kosmider, Thibault Comont, Mael Heilblig, Juan I. Arostegui, Annmarie Bosco, Rim Bourguiba, Katherine R. Calvo, Catherine Cargo, Chiara Cattaneo, François Chasset, Henrique Coelho, Corrado Campochiaro, Francesca Crisafulli, Stephanie Ducharme‐Benard, Raquel Faria, Franco Franceschini, Micol Frassi, Emma M. Groarke, Carmelo Gurnari, Yervand Hakobyan, Yvan Jamilloux, Ciprian Jurcut, Yohei Kirino, Austin Kulasekararaj, Hiroyoshi Kunimoto, Lauren M. Madigan, Heřman F. Mann, Chiara Marvisi, Marcin Milchert, Sara Morais, Katja Sockel, Francesco Muratore, Hideaki Nakajima, Mrinal M. Patnaik, Luísa Regadas, Marie Robin, Abraham Rutgers, Carlo Salvarani, Anthony M. Sammel, Joerg Seebach, Pierre Sujobert, Alessandro Tomelleri, Geoffrey Urbanski, Frédéric Vandergheynst, Romana Vieira, David S. Viswanatha, Ewa Więsik‐Szewczyk, Elisa Diral, Benjamin Terrier, Bhavisha A. Patel, Pierre Fenaux, Peter C. Grayson, David B. Beck, on behalf of the International VEXAS working group, and with endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases, Heřman Mann, Benjamin Terrier, François Chasset, Sophie Georgin Lavialle, Alessandro Tomelleri, Campochiaro Corrado, Carlo Salvarani, Francesca Crisafulli, Franco Franceschini, Micol Frassi, Yohei Kirino, Ewa Więsik‐Szewczyk, Marcin Milchert, Raquel Faria, Ciprian Jurcut, Joerg Seebach, Sinisa Savic, David Beck, Lauren Madigan, Matthew Koster, Patnaik Mrinal, Olivier Kosmider, Pierre Sujobert, Juan I. Arostegui, Catherine Cargo, David Viswanatha, Yervand Hagopian, Mael Heilblig, Pierre Fenaux, Thibault Comont, Bruno Alessandro, Chiara Cattaneo, Elisa Diral, Sara Morais, Austin Kulasekarara, Emma Groarke, Katherine Calvo, Patel Bhavisha, Anthony Sammel, Arsene Mekinian, Benjamin Terrier, Marie Robin, Sophie Georgin Lavialle, Katja Sockel, Yvan Jamilloux, Carmelo Gurnari, Henrique Coelho, Romana Vieira, Rim Bourguiba, Marcela Ferrada, Peter Grayson +111 morewiley +1 more sourceComparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
Arthritis &Rheumatology, EarlyView.Objective
The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods
This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, Valentin Lacombe, Vincent Jachiet, Michael Zisapel, Iftach Sagy, Oshrat E. Tayer‐Shifman, David Ozeri, Shaye Kivity, Alessandro Tomelleri, Benjamin Terrier, Hagit Peleg, Thibault Comont, Karim Sacre, Pascal Woaye‐Hune, Laurent Arnaud, Estibaliz Lazaro, Vincent Grobost, Francois Lifermann, Maxime Samson, Samuel Ardois, Alice Garnier, Alexandre Maria, Alain Cantagrel, Aurore Meyer, Jean‐David Bouaziz, Mael Heiblig, Lorenzo Dagna, Elisa Diral, Olivier Kosmider, Ori Elkayam, Jérôme Hadjadj, Sophie Georgin‐Lavialle, Olivier Fain, Arsene Mekinian +35 morewiley +1 more sourceGene Therapy in Patients with Transfusion‐Dependent β‐Thalassemia
New England Journal of Medicine, 2018 A. Thompson, M. Walters, J. Kwiatkowski, J. Rasko, J. Ribeil, S. Hongeng, E. Magrin, G. Schiller, E. Payen, M. Semeraro, D. Moshous, F. Lefrère, H. Puy, P. Bourget, A. Magnani, L. Caccavelli, J. Diana, F. Suarez, F. Monpoux, V. Brousse, C. Poirot, C. Brouzes, J. Meritet, C. Pondarré, Y. Beuzard, S. Chrétien, T. Lefèbvre, D. Teachey, U. Anurathapan, P. Ho, C. von Kalle, M. Kletzel, E. Vichinsky, S. Soni, G. Veres, O. Nègre, R. W. Ross, D. Davidson, Alexandria Petrusich, L. Sandler, M. Asmal, O. Hermine, M. de Montalembert, S. Hacein-Bey-Abina, S. Blanche, P. Leboulch, M. Cavazzana +46 moresemanticscholar +1 more source
